Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Post by RazeKreationson Feb 03, 2021 7:48pm
182 Views
Post# 32466393

Take a breath

Take a breathI know everybody would like to see MBX stock take off, especially the short term and day traders.
It will happen when there are at least 2 consecutive quarters with improvement in bottom line of the business. This first quarter will show the beginnings of the increase in Qap's and Antigens. But don't expect dramatic increase until second quarter which will be posted in May. MBX stock is an extremly good value now for the longer term investor that is looking for very good returns over several months and building up retirement portfolios. A good value now should be in the $1 to $1.50 range after the first quarter report and then increase after the second quarter report when i believe then the portfolio managers will come on board promoting the stock. Robert McWhirter has promoted MBX several times all based on Kinlytic and we all know how that worked out. He will be hesitant to promote again until ther is proof of profitability. And that will be happening these next 2 quarters.
When that happens you will be glad you purchased the stock now while it is an extremly good bargain.
IMHO
<< Previous
Bullboard Posts
Next >>